| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q4 2024 | 7 | 186,937 | DAVE, TALK, MBX, UDMY | 13F-HR | 2/10/2025 | 000110465925010945 |
| Q3 2024 | 8 | 176,148 | MBX BIOSCIENCES INC, ZENAS BIOPHARMA INC, TALK, DAVE | 13F-HR | 11/12/2024 | 000110465924116813 |
| Q2 2024 | 6 | 91,271 | TALK, UDMY, DAVE, OPEN | 13F-HR | 8/13/2024 | 000110465924088976 |
| Q1 2024 | 6 | 125,942 | TALK, UDMY, DAVE, OPEN | 13F-HR | 5/10/2024 | 000110465924059924 |
| Q4 2023 | 6 | 112,095 | UDMY, TALK, OPEN, GROV | 13F-HR | 2/14/2024 | 000110465924023698 |
| Q3 2023 | 8 | 111,700 | UDMY, TALK, OPEN, GROV | 13F-HR | 11/8/2023 | 000110465923115739 |
| Q2 2023 | 9 | 114,648 | UDMY, TALK, OPEN, GROV | 13F-HR | 8/1/2023 | 000110465923086375 |
| Q1 2023 | 8 | 86,931 | UDMY, TALK, OPEN, GROV | 13F-HR | 5/15/2023 | 000110465923060795 |
| Q4 2022 | 8 | 102,461 | UDMY, IMPL, TALK, GROV | 13F-HR | 2/14/2023 | 000110465923020374 |